Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
0445T
|
Subsequent placement of a drug-eluting ocular insert under one or more eyelids including re-training and removal of existing insert unilateral or bilateral
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0445U
|
B-amyloid (Abeta42) and phospho tau (181P) (pTau181) electrochemiluminescent immunoassay (ECLIA) cerebral spinal fluid ratio reported as positive or negative for amyloid pathology
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0446T
|
Creation of subcutaneous pocket with insertion of implantable interstitial glucose sensor including system activation and patient training
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0446U
|
Autoimmune diseases (systemic lupus erythematosus [SLE]) analysis of 10 cytokine soluble mediator biomarkers by immunoassay plasma individual components reported with an algorithmic risk score for current disease activity
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0447T
|
Removal of implantable interstitial glucose sensor from subcutaneous pocket via incision
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0447U
|
Autoimmune diseases (systemic lupus erythematosus [SLE]) analysis of 11 cytokine soluble mediator biomarkers by immunoassay plasma individual components reported with an algorithmic prognostic risk score for developing a clinical flare
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0448T
|
Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new implantable sensor including system activation
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0448U
|
Oncology (lung and colon cancer) DNA qualitative next-generation sequencing detection of single-nucleotide variants and deletions in EGFR and KRAS genes formalin-fixed paraffin-embedded (FFPE) solid tumor samples reported as presence or absence of targeted mutation(s) with recommended therapeutic options
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0449T
|
Insertion of aqueous drainage device without extraocular reservoir internal approach into the subconjunctival space; initial device
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0449U
|
Carrier screening for severe inherited conditions (eg cystic fibrosis spinal muscular atrophy beta hemoglobinopathies [including sickle cell disease] alpha thalassemia) regardless of race or self-identified ancestry genomic sequence analysis panel must include analysis of 5 genes (CFTR SMN1 HBB HBA1 HBA2)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0450T
|
Insertion of aqueous drainage device without extraocular reservoir internal approach into the subconjunctival space; each additional device (List separately in addition to code for primary procedure)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0450U
|
Oncology (multiple myeloma) liquid chromatography with tandem mass spectrometry (LC-MS/MS) monoclonal paraprotein sequencing analysis serum results reported as baseline presence or absence of detectable clonotypic peptides
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0451T
|
Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system endovascular approach and programming of sensing and therapeutic parameters; complete system (counterpulsation device vascular graft implantable vascular hemostatic seal mechano-electrical skin interface and subcutaneous electrodes)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0451U
|
Oncology (multiple myeloma) LC-MS/MS peptide ion quantification serum results compared with baseline to determine monoclonal paraprotein abundance
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0452T
|
Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system endovascular approach and programming of sensing and therapeutic parameters; aortic counterpulsation device and vascular hemostatic seal
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0452U
|
Oncology (bladder) methylated PENK DNA detection by linear target enrichment-quantitative methylation-specific real-time PCR (LTE-qMSP) urine reported as likelihood of bladder cancer
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0453T
|
Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system endovascular approach and programming of sensing and therapeutic parameters; mechano-electrical skin interface
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0453U
|
Oncology (colorectal cancer) cell-free DNA (cfDNA) methylation-based quantitative PCR assay (SEPTIN9 IKZF1 BCAT1 Septin9-2 VAV3 BCAN) plasma reported as presence or absence of circulating tumor DNA (ctDNA)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0454T
|
Insertion or replacement of a permanently implantable aortic counterpulsation ventricular assist system endovascular approach and programming of sensing and therapeutic parameters; subcutaneous electrode
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0454U
|
Rare diseases (constitutional/heritable disorders) identification of copy number variations inversions insertions translocations and other structural variants by optical genome mapping
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.